A notable finding from the in vivo studies is the ability of RGD4C/AAVP‐Grp78‐HSVtk vector plus GCV to produce a destruction of the GBM stem cells in vivo within the tumors and its enhancement in the presence of TMZ. The gene discussed is HSPA5; the disease is glioblastoma.